Desk›Healthcare› Onesource Specialty Pharma Ltd
Onesource Specialty Pharma Ltd
BSE 544292 · NSE ONESOURCE · ISIN INE013P01021 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹1,533.00
+1.03%
BSE close, 28 August 2026
₹17,579.35 cr
11.5 cr shares · Small cap
₹12,034.37 cr
as published
369.4× · 43.18×
EPS ₹4.15 · BV ₹35.50
1,405.38 / 21.21
₹ cr, as filed
16
3 selected · 19%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -20.3% |
|---|---|
| Against 52-week low | +42.6% |
| Day change | +1.03% |
| Size band | Small cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹4.15 |
|---|---|
| Price / earnings | 369.40× |
| Price / book | 43.18× |
| Book value — derived, price ÷ P/B | ₹35.50 |
| Return on equity | 11.70% |
| Operating margin | 26.41% |
| Net margin | 11.47% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 11.69%
- ROE as published
- 11.70%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 446.47 | 51.23 | 4.47 | 26.41% | 11.47% |
| Mar-26 · Q | 418.96 | 21.48 | 1.87 | 18.73% | 5.13% |
| FY25-26 | 1,405.38 | 21.21 | 1.85 | 19.82% | 1.51% |
Quarter on quarter
- Revenue, quarter on quarter
- +6.6%
- Net profit, quarter on quarter
- +138.5%
- Operating margin, quarter on quarter
- +768 bps
Disclosure profile 16 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Management | 1 |
| Concall Transcript | 1 |
| Credit Rating | 1 |
| Selected sub-total | 3 |
| Procedural | |
| AGM / EGM | 3 |
| Analyst / Investor Meet | 2 |
| Annual Report | 2 |
| Auditor Appointment | 1 |
| BRSR | 1 |
| ESOP Allotment | 1 |
| General | 1 |
| Newspaper Publication | 1 |
| Trading Window | 1 |
| Procedural sub-total | 13 |
| Total | 16 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 98 trading days
16 filings · 3 selected · busiest 2026-08-31
Filing rhythm · the twelve most recent
2026-08-312026-09-25
SelectedProcedural
Filings
16 in the window · 11 earlier on record
-
25 September 2026 ·
Allotment of ESOP / ESPS
Allotment of 900 Equity shares of Re. 1 each under ONESOURCE ESOP 2021 on September 25, 2026
Company Update / Allotment of ESOP / ESPS View filing →
-
25 September 2026 ·
Closure of Trading Window
Closure of trading window for the quarter ended September 30, 2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
25 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting results along with Scrtuinizer's report for the 19th AGM
AGM/EGM / AGM View filing →
-
23 September 2026 ·
Appointment of Statutory Auditor/s
Intimation of appointment of M/s BSR and Co. LLP as the Statutory Auditors of the Company for a term of 5 consecutive years.
Company Update / Appointment of Statutory Auditor/s View filing →
-
23 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 19th AGM (2nd AGM Post Listing) of the Company
AGM/EGM / AGM View filing →
-
11 September 2026 ·
General Update
Addendum to the notice of the 19th AGM scheduled to be held on September 23, 2026
Company Update / General View filing →
-
3 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of the investor presentation
Company Update / Analyst / Investor Meet View filing →
-
1 September 2026 ·
Newspaper Publication
Newspaper advertisement confirming the dispatch of the notice convening the 19th AGM of the Company and Remote e-voting
Company Update / Newspaper Publication View filing →
-
31 August 2026 ·
Notice Of The 19Th AGM Dated September 23, 2026
Intimation of the Notice of the 19th AGM (2nd AGM after listing), to be held on September 23, 2026 at 5:00 pm through Video Conferencing or other Audio Visual Means
AGM/EGM / AGM View filing →
-
31 August 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the FY 2026
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
31 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for FY 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
31 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for FY 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
31 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Investors called scheduled on September 03, 2026 at 10:00 AM.
Company Update / Analyst / Investor Meet View filing →
-
18 August 2026 ·
Credit Rating
Intimation of Credit Rating issued by India Ratings and Research Private Limited vide press release dated August 17, 2026
Company Update / Credit Rating View filing →
-
31 July 2026 ·
Earnings Call Transcript
Intimation of Transcript of Earnings call dated July 25, 2026
Company Update / Earnings Call Transcript View filing →
-
27 July 2026 ·
Change in Management
Changes in Senior Management Personnel (SMP) of the Company - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Company Update / Change in Management View filing →
RSS feed for Onesource Specialty Pharma Ltd · the 50 most recent filings